{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:30:35Z","timestamp":1785339035916,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008530","name":"University of Miami School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG068110"],"award-info":[{"award-number":["AG068110"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI073961"],"award-info":[{"award-number":["P30AI073961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI108472"],"award-info":[{"award-number":["R01AI108472"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.092","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T02:30:12Z","timestamp":1630290612000},"page":"6019-6024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers"],"prefix":"10.1016","volume":"39","author":[{"given":"Suresh","family":"Pallikkuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-4387","authenticated-orcid":false,"given":"Michael","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2021.08.092_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.092_b0010","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.092_b0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41577-020-00460-4","article-title":"Cross-reactive memory T cells and herd immunity to SARS-CoV-2","volume":"20","author":"Lipsitch","year":"2020","journal-title":"Nat Rev Immunol."},{"issue":"6512","key":"10.1016\/j.vaccine.2021.08.092_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans","volume":"370","author":"Mateus","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.092_b0025","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1080\/21645515.2020.1773141","article-title":"Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?","volume":"16","author":"Anbarasu","year":"2020","journal-title":"Hum Vaccin Immunother."},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.092_b0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjmed.2020.10.003","article-title":"MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness","volume":"134","author":"Ashford","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2021.08.092_b0035","doi-asserted-by":"crossref","unstructured":"Gold JE, Baumgartl WH, Okyay RA, Licht WE, Fidel PL, Jr., Noverr MC, et al. Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection? mBio. 2020;11.","DOI":"10.1128\/mBio.02628-20"},{"key":"10.1016\/j.vaccine.2021.08.092_b0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.puhe.2020.05.042","article-title":"TB infection and BCG vaccination: are we protected from COVID-19?","volume":"185","author":"Madan","year":"2020","journal-title":"Public Health."},{"issue":"15","key":"10.1016\/j.vaccine.2021.08.092_b0045","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.3390\/ijerph17155589","article-title":"BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study","volume":"17","author":"Urashima","year":"2020","journal-title":"Int J Environ Res Public Health."},{"issue":"10236","key":"10.1016\/j.vaccine.2021.08.092_b0050","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"issue":"30","key":"10.1016\/j.vaccine.2021.08.092_b0055","doi-asserted-by":"crossref","first-page":"17720","DOI":"10.1073\/pnas.2008410117","article-title":"BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)","volume":"117","author":"Escobar","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.092_b0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.092_b0065","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-020-0389-z","article-title":"Pre-existing immunity to SARS-CoV-2: the knowns and unknowns","volume":"20","author":"Sette","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.vaccine.2021.08.092_b0070","doi-asserted-by":"crossref","unstructured":"da Silva Antunes R, Pallikkuth S, Williams E, Esther DY, Mateus J, Quiambao L, et al. Differential T cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers. J Infect Dis. 2021.","DOI":"10.1101\/2021.01.12.21249683"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.092_b0075","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/infdis\/jiu840","article-title":"HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine","volume":"211","author":"George","year":"2015","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.092_b0080","doi-asserted-by":"crossref","unstructured":"Pallikkuth S, de Armas LR, Rinaldi S, George VK, Pan L, Arheart KL, et al. Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study. PLoS Biol. 2019;17:e3000257.","DOI":"10.1371\/journal.pbio.3000257"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.092_b0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/vaccines7040181","article-title":"A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro","volume":"7","author":"Tapia-Calle","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.092_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67172-6","article-title":"T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients","volume":"10","author":"L\u2019Huillier","year":"2020","journal-title":"Sci Rep."},{"issue":"7833","key":"10.1016\/j.vaccine.2021.08.092_b0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.08.092_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2017.11.002","article-title":"Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host","volume":"28","author":"Zheng","year":"2018","journal-title":"Curr Opin Virol."},{"issue":"26","key":"10.1016\/j.vaccine.2021.08.092_b0105","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1073\/pnas.0800502105","article-title":"Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution","volume":"105","author":"Zeng","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.vaccine.2021.08.092_b0110","article-title":"Alterations in T and B cell function persist in convalescent COVID-19 patients","author":"Shuwa","year":"2021","journal-title":"Med (N Y)"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.092_b0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.092_b0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe."},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.092_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08659-3","article-title":"Outcomes of controlled human malaria infection after BCG vaccination","volume":"10","author":"Walk","year":"2019","journal-title":"Nat Commun."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:31Z","timestamp":1759402891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2101152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":25,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X2101152X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}